Phase I Study of SU5416, a Small Molecule Inhibitor of the Vascular Endothelial Growth Factor Receptor (VEGFR) in Refractory Pediatric Central Nervous System Tumors
Pediatric Blood and Cancer - United States
doi 10.1002/pbc.21873
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2009
Authors
Publisher
Wiley